Tumor-infiltrating lymphocytes, forkhead box P3, programmed death ligand-1, and cytotoxic T lymphocyte–associated antigen-4 expressions before and after neoadjuvant chemoradiation in rectal cancer

作者: Feifei Teng , Xiangjiao Meng , Li Kong , Dianbin Mu , Hui Zhu

DOI: 10.1016/J.TRSL.2015.06.019

关键词: Cytotoxic T cellColorectal cancerMyeloid-derived Suppressor CellLymph nodeTumor-infiltrating lymphocytesNatural killer cellPD-L1Cancer researchChemoradiotherapyBiologyPathology

摘要: Preclinical studies have suggested that cytotoxic agents and radiation may partly deliver their antitumor activities by activating immune response. However, the alterations of tumor microenvironment including immunosuppressive molecules during chemoradiotherapy associations with clinical features prognosis in rectal cancer not been thoroughly investigated. Therefore, we investigate densities cluster differentiation 8 (CD8) positive tumor-infiltrating lymphocytes (TILs), CD4+TILs, natural killer cell (NK)-TILs, myeloid-derived suppressor cells (MDSCs), transcription factor forkhead box P3 (FOXP3)+TILs, programmed death ligand-1 (PD-L1), T lymphocyte-associated antigen-4 (CTLA-4) before after neoadjuvant (nCRT) patients to determine predictive prognostic effects. We screen 62 who underwent nCRT followed radical surgery. Pretreatment biopsy specimens posttreatment surgically resected all are retrieved perform immunohistochemistry CD8, CD4, CD56, FOXP3, CD33, CD11b, PD-L1, CTLA-4. The CD8+TILs CD4+TILs post-nCRT significantly higher than pre-nCRT (P = 0.004 0.005, respectively). Expressions MDSC, FOXP3+TILs, CTLA-4 relative stable nCRT. Tumors high density CD8+TILs, low MDSC-TILs more sensitive 0.022, 0.022 High pretreatment associated better disease-free survival overall 0.016 NK-TILs detected only 6 evaluated. Cell surface PD-L1 (1 62) stroma (3 very low. conclude immunity is activated increased infiltrating CD8+ CD4+ numbers MDSC-TILs, coinhibitory molecules. Pre-nCRT marker for response CRT, prognosis.

参考文章(50)
Alexander M. Aliper, Victoria P. Frieden-Korovkina, Anton Buzdin, Sergey A. Roumiantsev, Alex Zhavoronkov, Interactome analysis of myeloid-derived suppressor cells in murine models of colon and breast cancer. Oncotarget. ,vol. 5, pp. 11345- 11353 ,(2014) , 10.18632/ONCOTARGET.2489
Cynthia A. Chambers, Astar Winoto, James P. Allison, Francis Ka Ming Chan, Jeff Hanke, Monika C. Brunner, CTLA-4-Mediated Inhibition of Early Events of T Cell Proliferation Journal of Immunology. ,vol. 162, pp. 5813- 5820 ,(1999)
Shimon Sakaguchi, Noriko Sakaguchi, Misako Itoh, Masanao Asano, Masaaki Toda, Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. Journal of Immunology. ,vol. 155, pp. 1151- 1164 ,(1995)
Alexander Plotnikov, Be'eri Niego, Rachel Ophir, Rafi Korenstein, Yona Keisari, Effective treatment of mouse metastatic prostate cancer by low electric field enhanced chemotherapy. The Prostate. ,vol. 66, pp. 1620- 1630 ,(2006) , 10.1002/PROS.20435
Steven K. Seung, Brendan Curti, Marka Crittenden, Walter Urba, Radiation and immunotherapy: Renewed allies in the war on cancer. OncoImmunology. ,vol. 1, pp. 1645- 1647 ,(2012) , 10.4161/ONCI.21746
Li-wei Zhao, Chun Li, Rui-lan Zhang, Hao-gang Xue, Fu-xi Zhang, Fan Zhang, Xiao-dong Gai, B7-H1 and B7-H4 expression in colorectal carcinoma: correlation with tumor FOXP3(+) regulatory T-cell infiltration. Acta Histochemica. ,vol. 116, pp. 1163- 1168 ,(2014) , 10.1016/J.ACTHIS.2014.06.003
Eiji Shinto, Kazuo Hase, Yojiro Hashiguchi, Akinori Sekizawa, Hideki Ueno, Atsushi Shikina, Yoshiki Kajiwara, Hirotoshi Kobayashi, Megumi Ishiguro, Junji Yamamoto, CD8+ and FOXP3+ tumor-infiltrating T cells before and after chemoradiotherapy for rectal cancer. Annals of Surgical Oncology. ,vol. 21, pp. 414- 421 ,(2014) , 10.1245/S10434-014-3584-Y
Colin H. Richards, Campbell S.D. Roxburgh, Arfon G. Powell, Alan K. Foulis, Paul G. Horgan, Donald C. McMillan, The clinical utility of the local inflammatory response in colorectal cancer. European Journal of Cancer. ,vol. 50, pp. 309- 319 ,(2014) , 10.1016/J.EJCA.2013.09.008
Hazem Ghebeh, Shamayel Mohammed, Abeer Al-Omair, Amal Qattant, Cynthia Lehe, Ghofran Al-Qudaihi, Naser Elkum, Mohamed Alshabanah, Suad Bin Amer, Asma Tulbah, Dahish Ajarim, Taher Al-Tweigeri, Said Dermime, The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors. Neoplasia. ,vol. 8, pp. 190- 198 ,(2006) , 10.1593/NEO.05733